Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Abstract	The original version of this article unfortunately contained a mistake. The second sentence of the section "irAEs and ICI efficacy" should read as.
Authors	Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, Vaia Florou, Yukihiro Toi, Cynthia Cherry, Maida Hafiz, Andrea De Giglio, Mavish Muzaffar, Sandip H Patel, Shunichi Sugawara, Jarred Burkart, Wungki Park, Rita Chiari, Jun Sugisaka, Gregory A Otterson, Gilberto de Lima Lopes, Paul R Walker
Journal	Cancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 69 Issue 7 Pg. 1189 (07 2020) ISSN: 1432-0851 [Electronic] Germany
PMID	32347358 (Publication Type: Journal Article, Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!